Amylyx Pharmaceuticals, Inc. ( AMLX) - Stock Earnings
AMLX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
AMLX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -33.0 million USD | — USD |
| 2026Q1 | -41.3 million USD | — USD |
| 2026Q2 | -43.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AMLX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 49.3 million USD | 380.8 million USD |
| 2024 | -301.7 million USD | 87.4 million USD |
| 2025 | -144.7 million USD | — USD |
| 2026 Est. | — | — |
AMLX
Price: $27.65
52 week price:
Earnings Per Share: -1.47 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 390250
Market Capitalization: 3.1 billion